Sirio Pharma Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Peiqing Li
Chief executive officer
CN¥1.9m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 9.1yrs |
| CEO ownership | 9.2% |
| Management average tenure | no data |
| Board average tenure | 6yrs |
Recent management updates
Recent updates
CEO
Peiqing Li (58 yo)
9.1yrs
Tenure
CN¥1,882,300
Compensation
Mr. Peiqing Li serves as Chairman of the Board and General Manager at Sirio Pharma Company Limited since April 23, 2015.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman of the Board | 9.1yrs | CN¥1.88m | 9.2% CN¥ 647.5m | |
| Deputy GM & Director | 9.1yrs | CN¥1.66m | 7.48% CN¥ 526.1m | |
| Director | 9.1yrs | CN¥830.40k | 3.26% CN¥ 229.2m | |
| Director | 9.1yrs | CN¥1.90m | 2.59% CN¥ 182.1m | |
| Independent Director | 2.8yrs | CN¥120.00k | no data | |
| Independent Director | 2.8yrs | CN¥120.00k | no data | |
| Independent Director | 2.8yrs | CN¥120.00k | no data | |
| Non-Employee Supervisor | 2.8yrs | no data | no data |
6.0yrs
Average Tenure
53.5yo
Average Age
Experienced Board: 300791's board of directors are considered experienced (6 years average tenure).